Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • diarrhoea

Tag: diarrhoea

  • BiotechToday
  • World

Treating Irritable Bowel Syndrome with Low FODMAPs Diet

BioTech Today July 26, 2021July 26, 2021 2

Subhajit Nan, Amity University, Kolkata. Scientists have recently conducted clinical trials and made a critical meta-analysis on the effect of FODMAPS diet (abbreviated as fermentable oligosaccharides, disaccharides, monosaccharides, and polyols). These are considered to influence the stool habits and the overall quality of life of the patients suffering from irritable bowel syndrome (IBS). Subgroup analyses […]

Read More
  • BiotechToday
  • World

Novel Strategies for Clostridioides Difficile Infection Treatment

BioTech Today July 15, 2021July 14, 2021 2

Subhajit Nan, Amity University, Kolkata Clostridioides Difficile is a bacterium responsible for causing severe diarrhea and inflammation of the colon (colitis). Though guidelines for infection control measures are firmly in place, Clostridioides Difficile Infection or CDI remains the chief cause of diarrhea associated with healthcare. Since the burden associated with CDI is high, both from […]

Read More
  • BiotechToday
  • World

Campylobacter infection caused through sexual contact

bioxone May 25, 2021May 25, 2021 1

Aakancha Shaw, St. Xavier’s College, Kolkata According to the research done by an OU Hudson College of the public health faculty working in conjunction with colleagues in Denmark, a new type of bacterial spreading method has been found. The infection caused by campylobacter is one of the most common foodborne illnesses in the western world […]

Read More
  • BiotechToday
  • World

Study reveals SARS-CoV-2 prevents the formation of new red blood cells

bioxone November 4, 2020November 3, 2020 1

Sumedha Guha, Techno India University In a recent study conducted on lung samples obtained from 79 patients who died of COVID-19, researchers from the Far Eastern Federal University in Russia discovered the SARS-CoV-2 virus can not only damage red blood cells (RBCs) but also prevent the new formation of key red blood cells (namely, Erythrocytes).  […]

Read More
  • BiotechToday
  • World

Eatable antibody factories to combat deadly gut infections!

bioxone October 31, 2020October 31, 2020 2

Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune. Clostridioides difficile (C. diff) is a causative agent for diarrhoea and colitis (colon inflammation) and its infection occurs usually during or soon after the administration of antibiotics. This happens as a result of wiping out the gut microbiome. In the US, nearly 30,000 people die annually from C. diff […]

Read More
  • BiotechToday
  • World

One-pot Visual RT PCR as a diagnostic test for SARS-CoV-2

bioxone October 29, 2020October 28, 2020 1

Sumedha Guha, Techno India University The outbreak of the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) towards the latter part of 2019 had brought mankind to a screeching halt for some time. The global pandemic that followed in its wake is something that every nation of the world is still grappling hard to recover from. […]

Read More
  • BiotechToday
  • World

Is the frequent prescription of PPI medicines a boon or a bane?

bioxone October 18, 2020October 18, 2020 4

Husna, Amity University Kolkata Proton pump inhibitors (PPIs) are a class of medicines that work on the cells which are lining the stomach, reducing the production of acid in our stomach. They can treat heartburn and gastric acid reflux by irreversibly binding with the Na+ H+ ATPase located on the surface of gastric parietal cells.PPIs […]

Read More
  • BiotechToday
  • World

POTENCY OF PROBIOTICS ON DIGESTIVE DISORDERS AND ACUTE RESPIRATORY INFECTIONS

bioxone September 29, 2020September 28, 2020

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA The health problems and the mortality rate of children below 5 years of age is a serious threat globally especially to Asian and African countries. WHO reported Acute Respiratory Infection (ARI) and diarrhoea as the leading cause of death of ⅓ of children worldwide. Besides, protein-calorie malnutrition (PCM) is also […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy